SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950136-06-008513
Filing Date
2006-10-12
Accepted
2006-10-12 12:26:19
Documents
4
Period of Report
2006-10-06
Items
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 file1.htm 8-K 37048
2 CODE OF BUSINESS CONDUCT AND ETHICS file2.htm EX-14 157031
3 ebox.gif GRAPHIC 58
4 spacer.gif GRAPHIC 43
  Complete submission text file 0000950136-06-008513.txt   196169
Mailing Address 150 JOHN F. KENNEDY PARKWAY SUITE 100 SHORT HILLS NJ 07078
Business Address 150 JOHN F. KENNEDY PARKWAY SUITE 100 SHORT HILLS NJ 07078 44 1382 207506
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 061141497
SIC: 2834 Pharmaceutical Preparations